Samarkand Group plc : Exclusive Distribution Agreement (1266424)
January 10 2022 - 2:00AM
UK Regulatory
Samarkand Group plc (SMK) Samarkand Group plc : Exclusive
Distribution Agreement 10-Jan-2022 / 07:00 GMT/BST Dissemination of
a Regulatory Announcement, transmitted by EQS Group. The issuer is
solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
10th January 2022
Samarkand Group plc
("Samarkand", the "Company" or together with its subsidiaries
the "Group")
Exclusive Distribution Agreement
New 5 year Distribution Agreement with Dentyl Dual Action and
Ultradex oral care
Samarkand Group plc, the cross-border eCommerce technology,
services and consumer brand group, is pleased to announce a new
agreement with Venture Life plc (AIM: VLG) for the exclusive
distribution of their oral care brands Dentyl Dual Action and
Ultradex in China. Subject to minimum performance conditions, the
new agreement will be for an initial term of 5 years.
Venture Life plc is a leader in developing, manufacturing and
commercialising products for the self-care market. Dentyl Dual
Action is the fastest growing mouthwash brand in the UK and
Ultradex is the leader for UK halitosis mouthwash market[1]. Both
brands have previously generated sales in the Chinese market.
Samarkand Group plc will immediately become the brands' exclusive
distributor in both the cross-border ecommerce market and the
general trade market in China. Using its Nomad technology and
service capabilities, Samarkand will create multiple ecommerce and
retail sales channels for the brands.
Jerry Randall, CEO of Venture Life plc commented: "Samarkand
Group's commitment to transparency, experience, technology and
their ability to collaborate with us in both China and the UK were
important factors in our decision to appoint them. We are looking
forward to working with them on the growth of our brands in
China."
David Hampstead, CEO of Samarkand Group plc commented: "We are
delighted that Venture Life Group Plc has chosen Samarkand as their
new go to market partner for China. Dentyl and UltraDEX are market
leading brands with established recognition and sales in the
Chinese market. Samarkand's on the ground capability in China,
combined with our transparent and collaborative approach to working
with our brand partners, has once again made us the winning choice
for global brands.
We have significant experience in the personal care market in
China with our work on both client brands and our own brands,
Probio7 & Zita West. The oral care market is an exciting growth
space in China and working with an established group of brands that
can access both the cross-border ecommerce market and the general
retail market in China is a significant milestone for our group.
"
For more information, please contact:
Samarkand Group plc Via Alma PR
David Hampstead, Chief Executive Officer
http://samarkand.global/
Eva Hang, Chief Financial Officer
VSA Capital - AQSE Corporate Adviser and Broker +44(0)20 3005 5000
Andrew Raca, James Deathe, Pascal Wiese (Corporate Finance)
IPO@vsacapital.com
Andrew Monk (Corporate Broking)
Alma PR +44(0)20 3405 0213
Josh Royston
Robyn Fisher samarkand@almapr.co.uk
Joe Pederzolli
Notes to Editors
Samarkand is a cross-border eCommerce technology and retail
group focusing on connecting international Brands with China, the
world's largest eCommerce market. By connecting international
brands Samarkand is creating more choice for Chinese consumers and
making it possible for Chinese consumers to shop with brands cross
border. The Group has developed a proprietary software platform,
the Nomad platform, which is integrated across all necessary
touch-points required for eCommerce in China including eCommerce
platforms, payments, logistics, social media and customs. The Nomad
platform is the foundation on which the Group's Nomad technology
and service solutions are built. The core products include Nomad
Checkout, Nomad Storefront, Nomad Commerce and Nomad
Distribution.
The Company's current customer and own brand base comprises
leading European personal care, health and beauty brands such as
Probio7, Philip Kingsley, Zita West, Temple Spa, Baba West and
Napiers the Herbalists.
Founded in 2016, Samarkand is headquartered in London, UK with
offices in Shanghai and Tokyo employing over 160 staff.
For further information please visit
https://www.samarkand.global/
-----------------------------------------------------------------------------------------------------------------------
[1] Source: Venture Life Group PLC interim results 23rd
September 2021
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BLH1QT30
Category Code: MSCM
TIDM: SMK
Sequence No.: 135361
EQS News ID: 1266424
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1266424&application_name=news
(END) Dow Jones Newswires
January 10, 2022 02:00 ET (07:00 GMT)
Samarkand (AQSE:SMK)
Historical Stock Chart
From Jan 2025 to Feb 2025
Samarkand (AQSE:SMK)
Historical Stock Chart
From Feb 2024 to Feb 2025